88 related articles for article (PubMed ID: 27814773)
1. Retraction note: Metastatic ovarian papillary cystadenocarcinoma to the small intestine serous surface: report of a case of high-grade histopathologic malignancy.
Khaki F; Javanbakht J; Sharifzad S; Gharagozlou MJ; Khadivar F; Manesh JY; Hosseini SH; Anissian A; Touni SR; Gilvari A; Abdi FS
J Ovarian Res; 2016 Nov; 9(1):76. PubMed ID: 27814773
[No Abstract] [Full Text] [Related]
2. Metastatic ovarian papillary cystadenocarcinoma to the small intestine serous surface: report of a case of high-grade histopathologic malignancy.
Khaki F; Javanbakht J; Sharifzad S; Gharagozlou MJ; Khadivar F; Manesh JY; Hosseini SH; Anissian A; Touni SR; Gilvari A; Abdi FS
J Ovarian Res; 2014 Mar; 7():33. PubMed ID: 24636424
[TBL] [Abstract][Full Text] [Related]
3. Papillary cystadenocarcinoma: report of a case of high-grade histopathologic malignancy.
Cavalcante RB; da Costa Miguel MC; Souza Carvalho AC; Maia Nogueira RL; Batista de Souza L
Auris Nasus Larynx; 2007 Jun; 34(2):259-62. PubMed ID: 17045438
[TBL] [Abstract][Full Text] [Related]
4. Late recurrence of pStage 1 low-grade serous ovarian tumor presenting as a symptomatic bone metastasis: a case report.
Kubo C; Nagata S; Fukuda T; Kano R; Tanaka T; Nakanishi K; Ohsawa M; Nakatsuka SI
Diagn Pathol; 2018 Jun; 13(1):43. PubMed ID: 29960592
[TBL] [Abstract][Full Text] [Related]
5. Papillary serous carcinoma of the peritoneal surface: matched-case comparison with papillary serous ovarian carcinoma.
Killackey MA; Davis AR
Gynecol Oncol; 1993 Nov; 51(2):171-4. PubMed ID: 8276289
[TBL] [Abstract][Full Text] [Related]
6. WT1 immunoreactivity in uterine papillary serous carcinomas is different from ovarian serous carcinomas.
Goldstein NS; Uzieblo A
Am J Clin Pathol; 2002 Apr; 117(4):541-5. PubMed ID: 11939727
[TBL] [Abstract][Full Text] [Related]
7. PAX 2: a novel Müllerian marker for serous papillary carcinomas to differentiate from micropapillary breast carcinoma.
Chivukula M; Dabbs DJ; O'Connor S; Bhargava R
Int J Gynecol Pathol; 2009 Nov; 28(6):570-8. PubMed ID: 19851209
[TBL] [Abstract][Full Text] [Related]
8. Ovarian low-grade serous carcinoma involving the cervix mimicking a cervical primary.
Malpica A; Deavers MT
Int J Gynecol Pathol; 2011 Nov; 30(6):613-9. PubMed ID: 21979600
[TBL] [Abstract][Full Text] [Related]
9. Colonic carcinoma metastasis to ovary having serous cystadenocarcinoma -- an unusual case of double ovarian malignancy.
Visweswara RN; Prabhu VM
Cent Afr J Med; 1995 Nov; 41(11):357-9. PubMed ID: 8932579
[TBL] [Abstract][Full Text] [Related]
10. Mean nuclear volume in ovarian papillary serous cystadenocarcinoma.
Mohanty SK; Dey P; Saha SC
Anal Quant Cytol Histol; 2004 Feb; 26(1):28-30. PubMed ID: 15032078
[TBL] [Abstract][Full Text] [Related]
11. Primary Peritoneal Papillary Serous Cystadenocarcinoma - A Rare Malignancy.
Sahu SK; Agrawal S; Shirazi N; Kapruwan H; Dasgupta P; Ghildiyal D; Singh SN
Chirurgia (Bucur); 2015; 110(6):570-2. PubMed ID: 26713835
[TBL] [Abstract][Full Text] [Related]
12. IL-17A is elevated in sera of patients with poorly differentiated ovarian papillary serous cystadenocarcinoma.
Malekzadeh M; Dehaghani AS; Ghaderi A; Doroudchi M
Cancer Biomark; 2013 Jan; 13(6):417-25. PubMed ID: 24595078
[TBL] [Abstract][Full Text] [Related]
13. Progressive loss of selenium-binding protein 1 expression correlates with increasing epithelial proliferation and papillary complexity in ovarian serous borderline tumor and low-grade serous carcinoma.
Zhang C; Wang YE; Zhang P; Liu F; Sung CJ; Steinhoff MM; Quddus MR; Lawrence WD
Hum Pathol; 2010 Feb; 41(2):255-61. PubMed ID: 19896693
[TBL] [Abstract][Full Text] [Related]
14. Serous papillary cystadenocarcinoma associated with alpha-fetoprotein production.
Higuchi Y; Kouno T; Teshima H; Akizuki S; Kikuta M; Ohyumi M; Yamamoto S
Arch Pathol Lab Med; 1984 Sep; 108(9):710-2. PubMed ID: 6205636
[TBL] [Abstract][Full Text] [Related]
15. Are all pelvic (nonuterine) serous carcinomas of tubal origin?
Przybycin CG; Kurman RJ; Ronnett BM; Shih IeM; Vang R
Am J Surg Pathol; 2010 Oct; 34(10):1407-16. PubMed ID: 20861711
[TBL] [Abstract][Full Text] [Related]
16. Rare form of extraovarian peritoneal serous papillary carcinoma with solitary tumor in the abdominal wall: a case report and literature review.
Matsuura T; Sugihara K; Kohmura Y; Sugimura H; Kanayama N
J Obstet Gynaecol Res; 2009 Dec; 35(6):1142-7. PubMed ID: 20144179
[TBL] [Abstract][Full Text] [Related]
17. Carcinosarcoma of the ovary compared to papillary serous ovarian carcinoma: a SEER analysis.
Rauh-Hain JA; Diver EJ; Clemmer JT; Bradford LS; Clark RM; Growdon WB; Goodman AK; Boruta DM; Schorge JO; del Carmen MG
Gynecol Oncol; 2013 Oct; 131(1):46-51. PubMed ID: 23906658
[TBL] [Abstract][Full Text] [Related]
18. The development of high-grade serous carcinoma from atypical proliferative (borderline) serous tumors and low-grade micropapillary serous carcinoma: a morphologic and molecular genetic analysis.
Dehari R; Kurman RJ; Logani S; Shih IeM
Am J Surg Pathol; 2007 Jul; 31(7):1007-12. PubMed ID: 17592266
[TBL] [Abstract][Full Text] [Related]
19. Expression profiling of serous low malignant potential, low-grade, and high-grade tumors of the ovary.
Bonome T; Lee JY; Park DC; Radonovich M; Pise-Masison C; Brady J; Gardner GJ; Hao K; Wong WH; Barrett JC; Lu KH; Sood AK; Gershenson DM; Mok SC; Birrer MJ
Cancer Res; 2005 Nov; 65(22):10602-12. PubMed ID: 16288054
[TBL] [Abstract][Full Text] [Related]
20. Papillary serous adenocarcinoma of the uterine cervix: a report of three cases.
Gilks CB; Clement PB
Mod Pathol; 1992 Jul; 5(4):426-31. PubMed ID: 1495949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
